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Malaria parasites actively remodel the infected red blood
cell (irbc) by exporting proteins into the host cell cyto-
plasm. The human parasite Plasmodium falciparum ex-
ports particularly large numbers of proteins, including
proteins that establish a vesicular network allowing the
trafficking of proteins onto the surface of irbcs that are
responsible for tissue sequestration. Like P. falciparum,
the rodent parasite P. berghei ANKA sequesters via irbc
interactions with the host receptor CD36. We have applied
proteomic, genomic, and reverse-genetic approaches to
identify P. berghei proteins potentially involved in the
transport of proteins to the irbc surface. A comparative
proteomics analysis of P. berghei non-sequestering and
sequestering parasites was used to determine changes in
the irbc membrane associated with sequestration. Sub-
sequent tagging experiments identified 13 proteins (Plas-
modium export element (PEXEL)-positive as well as
PEXEL-negative) that are exported into the irbc cytoplasm
and have distinct localization patterns: a dispersed and/or
patchy distribution, a punctate vesicle-like pattern in the
cytoplasm, or a distinct location at the irbc membrane.
Members of the PEXEL-negative BIR and PEXEL-positive
Pb-fam-3 show a dispersed localization in the irbc cyto-
plasm, but not at the irbc surface. Two of the identified
exported proteins are transported to the irbc membrane
and were named erythrocyte membrane associated pro-
teins. EMAP1 is a member of the PEXEL-negative Pb-
fam-1 family, and EMAP2 is a PEXEL-positive protein en-
coded by a single copy gene; neither protein plays a direct
role in sequestration. Our observations clearly indicate
that P. berghei traffics a diverse range of proteins to
different cellular locations via mechanisms that are anal-
ogous to those employed by P. falciparum. This informa-
tion can be exploited to generate transgenic humanized
rodent P. berghei parasites expressing chimeric P. ber-
ghei/P. falciparum proteins on the surface of rodent irbc,
thereby opening new avenues for in vivo screening ad-
junct therapies that block sequestration. Molecular &
Cellular Proteomics 12: 10.1074/mcp.M112.021238, 426–
448, 2013.
Malaria parasites invade and develop inside red blood cells,
and extensive remodeling of the host cell is required in order
for the parasite to take up nutrients and grow (1). In addition,
infected red blood cells (irbcs)1 of several Plasmodium spe-
cies adhere to endothelium lining blood capillaries, and this is
achieved through modification of the irbc, specifically, alter-
ation of the irbc membrane (2, 3). This active remodeling of
the erythrocyte requires the export of parasite proteins into
the host cell cytoplasm and their incorporation in the irbc
membrane of the host cell (1, 2). Schizont-infected red blood
cells of the rodent parasite P. berghei ANKA adhere to endo-
thelial cells of the microvasculature, leading to the sequestra-
tion of irbcs in organs such as the lungs and adipose tissue
(4–6). P. berghei irbcs adhere to the class II scavenger re-
ceptor CD36 (7), which is highly conserved in mammals and is
the receptor most commonly used by irbcs infected with the
human parasite P. falciparum (8). These observations suggest
that P. berghei may export proteins onto the surface of irbcs
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in a fashion analogous to the processes employed by P.
falciparum that expresses PfEMP1, the protein known to be
responsible for P. falciparum irbc sequestration. However, P.
berghei does not contain Pfemp1 orthologs or proteins with
domains with clear homology to the domains of PfEMP1 (9),
and the P. berghei proteins responsible for irbc cytoadher-
ence and proteins involved in the transport of these proteins
to the irbc membrane remain largely unknown. Recently we
used a proteomic analysis of P. berghei ANKA irbc mem-
branes to identify parasite proteins associated with the eryth-
rocyte membrane, and we have demonstrated that the dele-
tion of a single-copy gene of P. berghei that encodes a small
exported protein known as SMAC results in strongly reduced
irbc sequestration (6). No evidence was found for the pres-
ence of SMAC on the irbc surface, and therefore this protein
is most likely involved in the transport or anchoring of other P.
berghei proteins that directly interact with host receptors on
endothelial cells.
For P. falciparum, a large number of exported proteins have
been predicted based on the presence of an N-terminal motif
known as the Plasmodium export element (PEXEL) motif (10,
11). Many of these PEXEL-positive proteins belong to spe-
cies-specific gene families. Comparison of PEXEL-positive
proteins in different Plasmodium species suggested that P.
falciparum expresses a significantly higher number of ex-
ported proteins than other Plasmodium species, which in part
can be attributed to the expansion of P. falciparum–specific
protein families, including those containing DnaJ or PHIST
domains (12–17). One explanation for the elevated number of
exported proteins in P. falciparum is that they are necessary
for export of the P. falciparum–specific protein PfEMP1 to the
irbc surface (10). Comparisons of different Plasmodium ex-
portomes have mainly focused on identifying orthologs of the
PEXEL-positive proteins of P. falciparum in the other species
(14, 15, 18). For example, of the 500 PEXEL-positive P.
falciparum proteins, only between 11 and 33 had orthologs in
P. berghei (14, 15, 19). However, such an approach might
underestimate the total number of exported proteins. A recent
hidden Markov model (HMM) analysis of the PEXEL motif for
P. berghei proteins identified at least 75 PEXEL-positive P.
berghei proteins (6). Moreover, in different Plasmodium spe-
cies, a number of exported proteins have been described that
are PEXEL-negative, indicating that alternative export path-
ways might exist that are independent of the presence of a
PEXEL motif (20, 21). It has been suggested that in species
with a small number of PEXEL-positive proteins, PEXEL-neg-
ative exported proteins play a more prominent role in host cell
remodeling (21). An example of a PEXEL-negative exported
protein family is the large PIR family of proteins, which are
expressed by rodent Plasmodium species (9, 22), the monkey
parasite P. knowlesi (23), and the human parasite P. vivax (24,
25).
To date, export to the irbc cytosol has been shown for only
a few P. berghei proteins (i.e. several members of the BIR
family; TIGR01590) (6), two members of the ETRAMP family
(26), and two proteins encoded by a single copy gene, SMAC
and IBIS1 (6, 27). In this study, comparative proteomic,
genomic, and reverse-genetic approaches have been used to
identify novel exported proteins of P. berghei. We report
proteome analyses of samples enriched for proteins associ-
ated with membranes of irbcs from both sequestering P.
berghei ANKA and non-sequestering P. berghei K173 para-
sites, and we also present analyses of the full genome se-
quence of a non-sequestering P. berghei K173 line. Fluores-
cent tagging of parasite proteins selected from the proteome
and genome analyses identified a number of novel P. berghei
ANKA proteins that are exported into the irbc cytoplasm. We
report for the first time the export of members of the PEXEL-
negative Pb-fam-1 gene family (pyst-a; TIGR01599) and show
that two proteins are transported to the P. berghei ANKA irbc
membrane. This is the first comprehensive study of exported
proteins of P. berghei that has been validated via the gener-
ation of a large number of transgenic P. berghei ANKA para-
sites expressing tagged proteins and has shown the export of
both PEXEL-positive and PEXEL-negative proteins to the irbc
cytoplasm. The identification of P. berghei ANKA proteins
exported to the irbc membrane and proteins involved in se-
questration suggests the possibility of developing “human-
ized” small animal models for the in vivo analysis of the
sequestration properties of P. falciparum proteins that would
express (domains of) P. falciparum proteins on the surface of
rodent irbcs (4, 6).
EXPERIMENTAL PROCEDURES
Experimental Animals and (Reference) L’Arbresle, France, P. ber-
ghei Lines—Female Swiss OF1 mice (6 to 8 weeks; Charles River) and
female Wistar rats (6 weeks) were used. All animal experiments of this
study were approved by the Animal Experiments Committee of the
Leiden University Medical Center (DEC 07171, DEC 10099). The
Dutch Experiments on Animal Act is established under European
guidelines (EU Directive No. 86/609/EEC regarding the Protection of
Animals used for Experimental and Other Scientific Purposes). Three
reference wild-type P. berghei ANKA parasite lines were used: (i) line
cl15cy1 (ANKAwt) (28); (ii) reporter line 1037cl1 (ANKA-GFP-Lucschiz;
mutant RMgm-32), which contains the fusion gene gfp-luc under
control of the schizont-specific ama1 promoter integrated into the
silent 230p gene locus (PBANKA_030600) and does not contain a
drug-selectable marker (5); and (iii) reporter line 676m1cl1 (ANKA-
GFP-Luccon; mutant RMgm-29), which contains the fusion gene gfp-
luc under control of the constitutive eef1 promoter integrated into
the silent 230p gene locus (PBANKA_030600) and does not contain a
drug-selectable marker (29). The following wild-type P. berghei K173
line was used: K173cl1, which is a clone from a laboratory line of the
K173 isolate (30) and was obtained from Department of Medical
Microbiology of the Radboud University Nijmegen Medical Center
(Nijmegen, The Netherlands). In addition, a mutant line of P. berghei
ANKA was used that lacks expression of SMAC (PBANKA_010060)
and does not contain a drug-selectable marker (parasite line
1242cl5m1cl1cl2, ANKAsmac; RMgm-662) (6).
Proteome Analyses of Samples Enriched for P. berghei ANKA and
P. berghei K173 Proteins Associated with Membranes of irbcs—Two
different methods were used to collect membrane fractions of Nyo-
denz-purified irbcs: the hypotonic lysis (HL) method and the surface
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shaving (SS) method, as described elsewhere (6). Membrane samples
were collected for irbcs containing purified, synchronized trophozo-
ites and schizonts of ANKAwt and K173cl1. In addition, membrane
samples were collected for irbcs containing purified, synchronized
schizonts of ANKAsmac. Trophozoite- and schizont-infected cells
were collected from synchronized infections in WISTAR rats as de-
scribed elsewhere (6). In brief, synchronized infections are estab-
lished by means of intravenous injection of cultured and purified
mature schizonts in rats. In these animals, merozoites invade within 3
to 4 h after injection of the schizonts, giving rise to synchronized
infections. Infected heart blood with a parasitemia of 1% to 3% and
containing ring forms is collected 4 h after schizont injection and
cultured for a period of 22 h using standardized in vitro culture
conditions after the removal of leukocytes, allowing the ring forms to
develop into trophozoites and schizonts. At 14 h and 22 h, irbcs are
collected containing single-nucleated, maturing trophozoites and ma-
turing schizonts, respectively. irbcs were separated from uninfected
red blood cells via Nycodenz density gradient centrifugation (28). The
HL and SS protein samples were analyzed via capillary liquid chro-
matography coupled on-line with tandem mass spectrometry (LC-
MS/MS), and acquired MS/MS spectra were analyzed as described
elsewhere (6).
In the newly generated in-depth proteome, every single sample
was analyzed at least three times via MS. For proteins identified by
one single peptide, that peptide was consistently identified across the
three independent MS runs. No single peptide identification was
accepted when the peptide was identified in a single or two MS runs.
We decided not to report the conventional protein coverage of plas-
modial proteins in this article, as in general it is low for several
reasons. It is known that Plasmodium exports a number of proteins to
the red blood cell surface, but levels of these proteins are remarkably
low relative to those of constitutive red blood cell proteins such as the
Band 3 (1 million copies/cell) or cytoskeletal proteins (1 105 copies/
cell). Furthermore, many of the Plasmodium-exported proteins belong
to protein families (for example, BIR, PFAM) that exhibit a high degree
of conservation among family members, thus reducing the amount of
unique peptides available for identification. In all these cases, there-
fore, the low protein coverage could become misleading and be
interpreted as a sign that our identifications are mainly low confi-
dence, which is not necessarily the case.
irbc Membrane Preparation—
HL—Packed schizont or trophozoite irbcs derived from the Nyco-
denz enrichment were repeatedly washed (at least three times) in cold
PBS buffer (pH 7.4). Thereafter, the samples were each re-suspended
in 50 ml ice-cold 5 mM phosphate buffer, pH 8, and centrifuged
(9000  g, 20 min, 4 °C). The hemolysate was discarded and the
operation was repeated (at least five times) until the supernatant
appeared colorless. Centrifugation was then increased to 20,000  g
and washing was repeated until the ghost membranes appeared
yellow-whitish. Membranes were stored at 80 °C.
SS—The schizont or trophozoite irbcs were repeatedly (at least
three times) washed with PBS (pH 7.4) and centrifuged for 5 min at
3000 rpm. Thereafter a 50% suspension in PBS was made, and 1.5
mg Trypsin (TRTPCK, Worthington) was added. Schizont samples
were incubated for 30, 45, or 60 min at room temperature in an effort
to determine the ideal surface shaving time. Trophozoite samples
were incubated for 45 min or 60 min at room temperature, as these
appeared to be the best time points (in terms of the number of
proteins/likely contaminants). irbcs were removed via centrifugation
(5 min at 3000 rpm) and their integrity was checked using Giemsa
staining. The supernatant was further cleared via centrifugation (15
min at 25,000  g) and stored at 80 °C, and the pellet was dis-
carded. Prior to MS analysis, the supernatants were reduced and
alkylated. Typically, 1 g DTT was added per 50 g protein, and this
was followed by incubation at room temperature for 30 min. Samples
were then supplemented with 5 g iodoacetamide per 50 g protein
(20 min, room temperature).
Protein Determinations—Proteins were measured using the Mi-
croBCA assay using BSA as a standard (Pierce) per the manufactur-
er’s instructions.
SDS-PAGE—Ten microliters of 10% (w/v) lithium dodecylsulfate
was added to 10-l samples, the mixture was heated (10 min, 70 °C),
and 10 l of this was run on a precast 4%–12% polyacrylamide gel
(NuPAGE, Invitrogen, Breda) in MOPS buffer supplemented with
0.025% (v/v) reducing agent (Invitrogen) in the inner chamber to
prevent sample reoxidation.
In-gel Digestion and Preparation for MS—SDS-PAGE track lengths
(top to tracking dye) averaged 7 cm and were cut into 10 slices, which
were individually digested as reported elsewhere (77). Aliqouts of
trypsin-digested material were diluted 1:5 with 0.5% glacial acidic
acid and 1% trifluoroacetic acid (v/v). Samples were loaded on a
stage tip (78) to desalt and stored for maximally 12 h at 4 °C. Peptides
were eluted three times in 10 l Buffer B (80% acetonitrile, 20%MilliQ
water, 0.5% glacial acidic acid v/v) directly into 96-well plates (AB-
0800, ABgene, Bath, UK), which were centrifuged under vacuum until
volumes were 4 to 6 l; this volume was then brought to 10 l with
Buffer A containing 0.3% trifluoroacetic acid.
MS—Trypsin-digested samples were analyzed via capillary LC-
MS/MS using an Agilent 1100 series system and an Orbitrap mass
spectrometer (Thermo Electron, Oberhausen, Germany) (three runs).
Samples from 3 g protein were separated via reverse-phase chro-
matography (3-m Reposil C18, 75 m  12 cm column) using a
gradient from 98% MS Buffer A and 2% MS Buffer B solution at 0.5
l/min flow rate. MS Buffer A was 0.5% glacial acidic acid v/v; MS
Buffer B was 80% acetonitrile and 0.5% glacial acidic acid v/v. At 24
min the flow was decreased to 0.25 l/min, and the amount of Buffer
B was serially increased to 7% (27 min), 13% (35 min), 33% (95 min),
50% (112 min), 60% (117 min), and finally 80% (123 min). Eluted
peptides were ionized to charge state 1, 2, or higher by the
electrospray source, and peptides that were at least doubly charged
were analyzed in data-dependent MS experiments with dynamic ex-
clusion. The MS method used was based on the three most intense
previously published ion methods (31), but it was modified to pick the
10 most intense ions instead of only three.
Database Search—Acquired MS/MS spectra were searched
against a decoy database composed of the non-redundant Interna-
tional Protein Index mouse sequence database (32) and the P. ber-
ghei Sanger Database using Mascot software (33). The use of the
decoy database allowed us to determine levels of false positive
peptide identifications. The estimated rate of peptide false positives
varied between 0.5% for the samples from the in-gel digestion and
0.6% to 0.7% for samples from the surface shaving. Search param-
eters for initial peptide and fragment mass tolerance were, respec-
tively, 5 ppm and 0.6 Da for the ANKA samples and 5 ppm/10
ppm and 0.6 Da/0.8 Da for the K173 samples, with allowances
made for one missed trypsin cleavage, fixed modification of cysteine
through carbamidomethylation, and acetylation and methionine oxi-
dation as variable modifications. Only fully tryptic peptide matches
were allowed.
Validation—Validation was based upon MSQuant (open source
software developed by our laboratory), enabling manual score and
spectrum evaluation of each peptide that led to the identification of a
given protein. Stringent protein identification criteria were imposed:
each protein required minimally a unique seven-amino-acid peptide
with a Mascot score 35 (corresponding to 99.9% identification
confidence for both ANKA and K173) and an MS/MS spectrum fea-
turing a continuous series of at least three y-ions in the area  y5 or
a continuous series of three y- or b-ions. Protein identifications by
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single peptides were allowed only if the protein in question was
identified at least in two runs. In the case of K173, less strict param-
eters were applied in terms of the Mascot score (25) and corre-
sponding identification confidence (95%).
Annotation—PlasmoDB (34) and GeneDB from The Welcome Trust
Sanger Institute Pathogen Sequencing Unit (35) were used for anno-
tation and to gain more information on the proteins of interest, such
as the presence/absence of trans-membrane domains, glycosylphos-
phatidylinositol anchors, and signal sequences; protein structure;
position in the chromosome; and environment. Ultimately, old P.
berghei protein identifiers were converted to the new P. berghei
ANKA strain annotation, which became available toward the end of
the study.
Search Parameters and Acceptance Criteria (MS/MS and/or Pep-
tide Mass Fingerprint data)—We used the peaklist-generating soft-
ware MSQuant v1.5 (release date: March 16, 2009) in combination
with DTA Supercharge v1.18 (release date: May 16, 2007). The search
engine was that of MASCOT software v2.3 (2009, Matrix Science,
London, UK) and was used January–March 2010.
A decoy database was generated using the publicly available In-
ternational Protein Index mouse database (v. 3.69, February 10, 2009;
113,982 entries) and the P. berghei Sanger Database (P. berghei
ANKA available from GeneDB; unpublished; sequence version July
2010, annotation version January 2012). The draft genome sequence
of P. berghei K173cl1 with the transferred annotation can be found at
the Sanger Institute web site. The numbers of entries in the database
(or subset of the database) actually searched were as follows: Inter-
national Protein Index mouse database (v. 3.69, February 10, 2009),
113,982 entries; P. berghei Sanger Database (P. berghei ANKA avail-
able from GeneDB; July 2010), 25,293 entries.
Generation of Lists of Putative/Predicted Exported Proteins Based
on Literature Searches and Presence of PEXEL Motif—The literature
was searched for all P. berghei proteins that have been predicted to
be exported based on the presence of the PEXEL motif or on exper-
imental evidence of export. We generated an “exported protein” list
(supplemental Table S2) that contained all predicted exported pro-
teins including the BIR protein family (99 genes; GeneDB, January
2011) and the Pb-fam-1 protein family (23 genes; GeneDB, January
2011). This list was based on (i) P. berghei proteins reported by
Sargeant et al. (13), van Ooij et al. (14), Maier et al. (19), and Pick et al.
(15); (ii) P. berghei orthologs of P. falciparum proteins that have been
defined as putative Maurer’s clefts proteins (36) or which belong to
the translocon of exported proteins (37); (iii) 75 P. berghei proteins
containing a PEXEL motif (6) (see below); and (iv) all proteins (62)
identified as “Plasmodium exported protein, unknown function” in
GeneDB (January 2011 version). Proteins of all the different catego-
ries are shown in supplemental Table S2. The PEXEL-containing
proteins were identified through HMM PEXEL searches as described
elsewhere (6). HMM searches were performed against all predicted P.
berghei ANKA proteins (PlasmoDB, 2010, release 7.0). To reduce the
number of false positives, all P. berghei sequences were truncated
prior to HMM searches to include only the first 100 amino acids in the
HMM analysis. A region of 100 amino acids is consistent with the
location of PEXEL motifs (38). In total, 438 proteins were retrieved
through the PEXEL HMM search (supplemental Table S1). Only pro-
teins with HMM scores of 2 were identified as PEXEL-positive
proteins in this study. Subsequent analysis showed that 67 of the 75
proteins contained a motif following the PEXEL consensus sequence
(RL), whereas for 8, either the R or the L was substituted by the
similarly charged amino acids K or I, respectively.
Genome Sequence of P. berghei K173cl1—DNA for sequencing
was collected from Nycodenz-purified schizonts collected from over-
night cultures of infected blood collected from rats infected with
K173cl1 parasites (39). In brief, infected blood with a parasitemia of
1% to 3% was collected via heart puncture from Wistar rats, leuko-
cytes were removed, and parasites were cultured overnight at 37 °C
using standard culture conditions. Schizont-infected red blood cells
from these cultures were separated from uninfected erythrocytes
using Nycodenz-gradient centrifugation. Approximately 1  109 schi-
zonts were resuspended in complete culture medium and passed
through two CS columns (Miltenyi Biotec, Leiden, The Netherlands) of
a VariaMACS magnetic cell separator for collecting schizonts as
described elsewhere (40, 41). This magnetic separation step in the
preparation of the Nycodenz-separated schizonts has been included
in order to reduce host (i.e. leukocyte-derived) DNA contamination.
Prior to purification, the MACS® column (CS columns, Miltenyi Biotec,
Germany) was filled from the bottom with complete culture medium
(RPMI1640  fetal calf serum, pH 7.3) at room temperature. Nyco-
denz-separated schizonts suspended in 6 ml (dead volume of the
column) of complete culture medium were then deposited on the top
of the column, which was held in a Quadro MACS® magnetic support.
The column was washed three times with 6 ml of complete culture
medium. The column was removed from the magnetic support, and
the schizonts were eluted twice with 6 ml of complete culture me-
dium. The recovered eluent was centrifuged to pellet the schizonts (10
min at 2200 rpm), and the supernatant was discarded. Purified schi-
zonts were stored at80 °C. To sequence the DNA samples, libraries
of 200 to 400 bp fragment length were generated following the
PCR-free protocol (42). The libraries were denatured and hybridized
to the flow cell. Next they were loaded onto an Illumina Genome
Analyzer IIX using the V4 SBS sequencing kit. Around 66 million 76-bp
reads were obtained with an insert size of 290 bp. Those reads would
provide 300 coverage of the P. berghei ANKA reference genome.
The sequences were deposited in the short read archive (http://
www.ebi.ac.uk/ena) with the accession number ERS002990. After
initial quality control, the reads were mapped with SMALT (version
5.3; standard parameter) against the genome sequence of P. berghei
ANKA (ANKAwt; available from GeneDB; unpublished; sequence ver-
sion date July 2010, annotation version January 2012). The resulting
bam file was used to call variant and coverage with mpileup and
bcftools from the SAMtool package (43). A PERL script catalogued,
for each gene, all types of variants (synonymous, non-synonymous
mutations, and indels), the number of unique bases, the amount of
covered bases, and the mean coverage of repetitive mapping reads.
The files with the mapped reads (bam) and the called variants (bcf)
can be found on the Wellcome Trust Sanger Institute web site, which
can be load in viewers such as Artemis cite pubmed 22253280. In
addition, a de novo assembly was generated using Velvet software
(44) with the following parameters: exp_cov auto, min_contig_lgth
500, cov_cutoff 20, ins_length 350. This resulted in the generation of
319 supercontigs. To improve the assembly, the PAGIT protocol was
used. In short, the supercontigs were ordered against the P. berghei
ANKA genome (ABACAS (45)), ignoring contigs smaller than 2 kb. A
total of 139 out of 161 contigs could be ordered against the reference
genome. Next we closed gaps with IMAGE (46), and small errors were
corrected with ICORN (47). From 5011 genes of the reference, the P.
berghei ANKA genome, we transferred 4998 completely and 2 par-
tially using RATT (48) (species parameter). As a last step, all contigs
that were not ordered against the P. berghei ANKA genome were
joined to a bin file. For some analyses, we combined all chromosomes
and the bin file to one “unionfile.” The draft genome sequence with
the transferred annotation can be found at the Wellcome Trust Sanger
Institute web site.
Generation, Selection, and Characterization of Transgenic Parasites
Expressing Tagged Proteins and Gene-deletion Mutants—Transfec-
tion of P. berghei parasites and selection and cloning of transgenic
and mutant parasite lines were performed as described elsewhere
(28); see below for details of the generation of DNA constructs for the
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tagging and gene-deletion studies. Correct integration of the DNA
constructs was determined via standard PCR and/or Southern blot
analysis of digested genomic DNA or chromosomes separated via
pulse-field gel electrophoresis. Southern blots were hybridized with
the following probes: 3UTR dhfr/ts of P. berghei ANKA and the
dhfr/ts gene of Toxoplasma gondii (supplemental Table S6).
The transcription of genes was determined via Northern analysis of
RNA obtained from blood stages of synchronous or asynchronous in
vivo infections. Northern blots were hybridized with the emap2 (prim-
ers 5755–5756), pbanka136550 (primers 6284–6285), and smac
(3423–3424) probes (supplemental Table S6C) and the a/b-large sub-
unit rRNA probe as a control (primer 644 (49)). SMAC and mCherry
expression was analyzed via Western analysis using, respectively,
rabbit polyclonal antibodies against a SMAC peptide (CTH-
GQYKYHRNNVYT-amide (6)) and anti-mCherry goat polyclonal anti-
bodies (Santa Cruz Biotechnology, Heidelberg, Germany; catalog no.
sc-33354, 1:1000). As a control for protein loading, nonspecific
mCherry hybridization bands or a mouse monoclonal antibody probe
recognizing P. berghei ANKA HSP70 (PBANKA_071190) was used.
EMAP1 polyclonal antibody was raised in rabbits against bacterial-
expressed EMAP1 protein fragment. A 900 bp PCR fragment was
amplified with primer set 5432 and 5433 and cloned in pET28b vector
(Invitrogen). The recombinant EMAP1 was purified via affinity chro-
matography under denaturing conditions and used for the immuniza-
tion of rabbits by Biogenes, Berlin, Germany.
For the analysis of mCherry or GFP expression of the transgenic
lines, live parasites were collected in PBS or complete 1640-RPMI
culture medium and examined via microscopy using a Leica DMR
fluorescent microscope with standard GFP, FITC, and Texas Red
filters. Parasite nuclei were labeled by means of staining with
Hoechst-33258 (Sigma), and red blood cell surface membranes were
stained with the anti-mouse TER-119-FITC labeled antibody (eBio-
science, Vienna, Austria). Briefly, erythrocytes were stained with TER-
119-FITC antibody (1:200) and Hoechst-33258 (2 mol/l) at room
temperature for 30 min and washed with 500 l of RPMI 1640 me-
dium (400g, 2 min). To detect mCherry exposed on the surface of live
parasites, parasites were first incubated with rabbit anti-mCherry
antibody (Clontech; 1:200) at room temperature for 30 min. After a
wash with 500 l of RPMI 1640 medium (400g, 2 min), parasites were
stained with Alexa fluor 488-labeled goat anti-rabbit (Invitrogen;
1:500) at room temperature for 30 min. For DNA visualization,
Hoechst-33258 (2 mol/l) was added during the incubation of the
secondary antibody. Pelleted cells (400g, 2 min) were resuspended in
RPMI 1640 medium.
For the analysis of fixed irbcs, the irbcs were fixed in 4% para-
formaldehyde in PBS for 10 min at room temperature, followed by a
single washing with PBS. The cells were applied on poly-L-lysine
(Sigma)–coated cover slips and air-dried. Cover slips were quenched
with 0.15% glycine (Merck, Schiphol-Rijk, The Netherlands) in PBS
for 10 min at room temperature, and this was followed by two washes
in PBS and incubation with 0.1% tritonX100 (Sigma) in PBS for 10 min
at room temperature. After a single washing with PBS, blocking was
done with complete 1640-RPMI culture medium with FCS, and cover
slips were then incubated overnight with the primary antibody, rabbit
polyclonal anti-EMAP1 (1:200, Biogenes, Berlin, Germany) at 4 °C.
This was followed with three washes, each for 5 min, with PBS at
room temperature. The secondary antibodies Alexa fluor 594-labeled
donkey anti-rabbit (Invitrogen; 1:500) with Hoechst-33258 (2 mol/l)
were applied on the cover slips for 2 h at room temperature. Cover
slips were washed three times for 5 min with PBS at room tempera-
ture and mounted in Vector shield (Vector Laboratories, Peterbor-
ough, UK). Microscopy images were recorded with a CoolSNAP HQ2
digital camera (Photometrics, Tucson, AZ) and processed with Col-
orProc software (50).
The percentage of blood stage parasites that expressed mCherry
was determined via FACS analysis of cultured blood stages. In brief,
infected tail blood (10 l) with a parasitemia between 0.5% and 3%
was cultured overnight in 1 ml complete RPMI1640 culture medium at
37 °C under standard conditions for the culture of P. berghei blood
stages (28, 51). Cultured blood samples were then collected and
stained with Hoechst-33258 (2 mol/l; Sigma) for 1 h at 37 °C in the
dark and analyzed using a FACScan (BD LSR II, BD Biosciences) with
filter 440/40 for Hoechst signals and filter 610/20 for mCherry fluo-
rescence. For FACS analysis, the population of mature schizonts was
selected based on their Hoeschst-fluorescence intensity (6); see gate
G1 in the left-hand FACS panel of Fig. 2B. The percentage of
mCherry-expressing parasites was calculated by dividing the number
of mCherry-positive schizonts (red gate G2 in left-hand FACS panel of
Fig. 2B) by the total number of mature schizonts (parasites with
8–16N DNA content, gate G1). Analysis of the percentage of
mCherry-expressing parasites labeled with FITC-anti-mCherry anti-
body was calculated by dividing the number of FITC-positive schi-
zonts (green gate G2 in right-hand FACS panel of Fig. 2B) by the total
number of mature schizonts (gate G1).
For gene deletion mutants, the in vivo multiplication rate of asexual
blood stages was determined during the cloning procedure as de-
scribed elsewhere (5). The percentage of infected erythrocytes in
Swiss mice (8 weeks old) injected with a single parasite was deter-
mined at days 8–11 in Giemsa-stained blood films. The mean asexual
multiplication rate per 24 h was then calculated assuming a total of
1.2  1010 erythrocytes/mouse (2 ml of blood). The percentage of
infected erythrocytes in mice infected with reference lines of the P.
berghei ANKA strain consistently ranged between 0.5% and 2% at
day 8 after infection, resulting in a mean multiplication rate of 10 per
24 h (5, 52).
The presence of non-sequestering schizonts in the peripheral
blood circulation was determined in tail blood of mice with synchro-
nized infections via FACS analysis and analysis of Giemsa-stained
blood films (6). For FACS analysis, 10 l of tail blood infected with
parasites expressing GFP-luciferase (under control of the schizont-
specific ama-1 promoter) was collected at 22 hpi in 1 ml of complete
culture medium, stained with Hoechst-33258 (2 mol/l) for 1 h at
37 °C, and analyzed for both Hoechst and GFP fluorescence with a
FACScan (LSR II). The fluorescence intensity and size (forward/side-
ward scatter) of a total of 50,000 cells per sample were measured,
and data analysis was performed using CellQuest software (BD Bio-
science). In the samples, the total number of immature and mature
schizonts (Gate G1: parasites with 2N DNA content) and of mature
schizonts (Gate G2: parasites expressing GFP) was determined (see
Fig. 5B for gates G1 and G2).
Tissue sequestration of schizonts in whole bodies of live mice and
in isolated organs was visualized through imaging of luciferase-ex-
pressing transgenic parasites with an intensified charge-coupled de-
vice photon counting video camera of the in vivo imaging system (IVIS
100 and Lumina, Caliper Life Sciences, Teralfene, Belgium) as de-
scribed elsewhere (7, 53). Sequestration patterns were monitored in
mice with synchronized and asynchronous infections. Synchronized
infections (1% to 3% parasitemia) were established via injection of
cultured, purified schizonts as described above. Imaging of schizonts
was performed between 15 and 24 h after infection of the mice.
Imaging of individual organs from mice with synchronized infections,
obtained via dissection from animals at 21 to 23 h after infection, was
done as described elsewhere (7, 53). Imaging data were analyzed
using the program LIVING IMAGE 4.2 (Caliper Life Sciences). Statis-
tical analyses were performed using Student’s t test with the Graph-
Pad Prism software package 5 (GraphPad Software, Inc., La Jolla,
CA).
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Generation of Transgenic K173cl1 Lines Expressing the Fusion
Protein GFP-luciferase under the Control of the ama1 Promoter—Two
transgenic K173cl1 lines (K173cl1-GFP-Lucschiz) were generated that
expressed the fusion protein GFP-luciferase under the control of the
schizont specific ama1 (gene model PBANKA_091500) promoter.
These lines, K173cl1-GFP-Lucschiz-a (line 1006cl1; RMG-375) and
K173cl1-GFP-Lucschiz-b (line 1272m1cl1, RMgm-716), contain the
GFP-luciferase gene integrated by either single-crossover or double-
crossover integration into the silent c/d-ssu-rRNA locus. K173cl1-
GFP-Lucschiz-b is drug-selectable-marker free, whereas K173cl1-
GFP-Lucschiz-a contains the dhfr/ts of T.gondii as a selectable marker.
Line K173cl1-GFP-Lucschiz-a has been generated as described for the
generation of a similar transgenic line in P. berghei ANKA (7) using
single-crossover plasmid pL0028. Line K173cl1-GFP-Lucschiz-b has
been generated and selected via FACS sorting as described (29)
using double-crossover plasmid pL1403. To generate pL1403, the
230p (PBANKA_030600) targeting regions of pL0023 were ex-
changed for the small subunit (18 S) of the S-type rRNA regions (5ssu
HindIII/PstI (primers: 3768 and 3769) and 3ssu Asp718/EcoRI (prim-
ers: 3770 and 3771)) to create pL0023ssdko. Subsequently, the
ama1-GFP fragment of pL1221 (53) was cloned (Asp718/PstI) to
obtain pL1384. Finally, the luciferase reporter gene of pL0028 (5) was
cloned as an HpaI/XbaI fragment. Plasmid pL1403 was linearized
using SacII (primers are listed in supplemental Table S6C).
Generation of Transgenic P. berghei ANKA and P. berghei K173
Parasites Expressing Tagged Proteins—To generate transgenic par-
asites expressing C-terminally tagged mCherry proteins, construct
pL1419 was used (6). The smac targeting region was then replaced by
a targeting region of the candidate genes listed in supplemental Table
S3. The primer information and restriction sites used are listed in
supplemental Table S6A.
To obtain the eGFP-tagging constructs, the eGFP-3cam fragment
was amplified using primer sets 6252 and 6253 from pBluescript-
eGFPcam (54), thereby introducing the linker upstream of the
mCherry gene of pL1419. This PCR product was then cloned in
pL1534 (supplemental Tables S3 and S6A) to create pL1746. Finally,
the tgdhfr-ts selectable cassette of pL1534 (Asp718) was introduced
to obtain pL1817 (emap1::eGFP). Subsequently, the emap1 fragment
of pL1817 was exchanged for the targeting region of PBANKA_
000320, PBANKA_072260, PBANKA_070110, or PBANKA_136550
(supplemental Tables S3 and S6A). To create pL1475, the
PBANKA_070110::eGFP fragment was cloned (NotI/KpnI) into
pL0034 (55).
To create pL1519 (supplemental Tables S3, S6A, and S6C), the first
and second exons of PBANKA_070110 were amplified with primer
sets 4373–4519 and 4522–4523, respectively, and the egfp gene was
amplified with primer set 4520–4521. Then the HindII site of pL0010
was destroyed via klenow filling, and this was followed by cloning of
egfp (BamHI/Asp718), PBANKA_070110 exon 2 (HindIII/Asp718), and
PBANKA_070110 exon 1 (BamHI/ClaI). The reporter gene egfp was
exchanged for mCherry (ClaI/HindIII; primer set 4654–4655), and
finally the amaI promoter was exchanged for the smac promoter of
pL1378 (BamH/XhoI (6)).
Transfection experiments were performed using ANKAwt, K173cl1,
or ANKAsmac parasites. Details of the DNA constructs and the
genotype analyses of all mutants have been submitted to the data-
base of genetically modified rodent malaria parasites (RMgmDB).
Generation of Transgenic K173cl Lines Expressing mCherry-tagged
SMAC, EMAP1, and EMAP2—A transgenic K173cl1 line (smac::
mCherryk713; line 1276cl1; RMgm-704) that expresses mCherry-
tagged SMAC (gene model PBANKA_010060) was generated as de-
scribed for tagging the smac gene of P. berghei ANKA using plasmid
pL1419 (6). Transgenic lines expressing mCherry-tagged EMAP1
(gene model PBANKA_083680; emap1::mCherryk173; lines 2131 and
2132; RMgm-691) and EMAP2 (gene model PBANKA_021550,
PBANKA_031680; emap2::mCherryK173; lines 2065 and 2066; RMgm-
702) were generated using the same procedures and plasmids,
pL1534 and pL1791, as used for tagging these emap1 and emap2 in
P. berghei ANKA (see below).
Generation of Transgenic ANKAsmac Lines Expressing mCherry-
tagged EMAP1 and EMAP2—Transgenic lines expressing mCherry-
tagged EMAP1 (gene model PBANKA_083680; emap1::
mCherrysmac; line 1847; RMgm-692) and EMAP2 (gene model
PBANKA_021550, PBANKA_031680; lines 2069 and 2070,
emap2::mCherrysmac; RMgm-703) were generated using the same
procedures and plasmids, pL1534 and pL1791, as used for tagging
these emap1 and emap2 in P. berghei ANKA (see below). Transfec-
tion was performed using the ANKAsmac3-sm parent line that lacks
a drug-resistance marker (line 1242cl5m2cl1; RMgm-662 (6)).
Generation of Gene Deletion ANKAwt Mutants and Unsuccessful
Attempts to Delete/Disrupt Genes—Two general gene-targeting DNA
constructs, pL0001 or pL0037 (available from MR4, Manassas, VA),
were used to generate constructs to disrupt the genes selected from
the proteome analyses. These constructs were aimed at targeted
gene disruption via double-crossover homologous recombination.
Sequences of the open reading frame and UTR regions of the se-
lected genes were retrieved from PlasmoDB and GeneDB. To replace
the open reading frame of the target genes with the selection cassette
containing the pyrimethamine-resistant dhfr/ts of T. gondii, the 5 and
3 flanking regions of the open reading frame were cloned up- and
down-stream of the selection cassette of pL0001 or pL0037. Four
constructs were made with an “anchor-tagging” PCR-based method
using pL0040 (56) with an anchor-tag suitable for the second PCR
reaction. The primers used to amplify the target regions are listed in
supplemental Table S6B. For each gene, at least two independent
transfection experiments were performed using P. berghei ANKA
parasites of reporter line 1037cl1. Details of the DNA constructs and
the genotype analyses of all mutants have been submitted to the
database of genetically modified rodent malaria parasites (RMgmDB).
RESULTS
P. berghei K173cl1 Parasites Lack a CD36-mediated Se-
questration Phenotype but Express and Export SMAC into the
irbc Cytoplasm—We analyzed genetic differences between
two P. berghei lines with sequestering (ANKAwt) and non-
sequestering (K173cl1) phenotypes to identify putative ex-
ported proteins. The K173cl1 parasites are derived from a
laboratory line of the P. berghei K173 isolate (30, 60) for which
evidence has been presented that schizonts do not sequester
(4, 61). Here we first compared the sequestration of K173cl1
and ANKAwt schizonts in more detail and subsequently com-
pared the genomes of both lines (see next section). Schizont
sequestration of K173cl1 was determined using transgenic
parasites that express the reporter fusion-protein GFP-lucif-
erase under the control of the schizont-specific ama1
promoter (K173cl1-GFP-Lucschiz; supplemental Fig. S1).
Schizont sequestration of these reporter parasites was sub-
sequently determined by quantifying schizonts in tail blood via
FACS analysis and quantifying schizont tissue sequestration
via real-time in vivo imaging. FACS analysis confirmed the
microscopic examination of Giemsa-stained smears of tail
blood of infected mice (i.e. the abundant presence of schi-
zonts in the peripheral blood circulation) (Figs. 1A–1C). Anal-
ysis of the tissue distribution of schizonts also revealed the
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FIG. 1. Schizonts of P. berghei K173cl1 do not sequester but remain in the blood circulation. A, FACS analysis of the presence of
schizonts in the peripheral blood circulation in mice (n 	 4) with synchronized infections with a parasitemia of 2% to 3%. Tail blood infected
with parasites expressing GFP-luciferase (under the ama-1 promoter) was stained with Hoechst and analyzed for Hoechst and GFP
fluorescence (upper panel). In K173cl1-infected mice, the total numbers of both schizonts (Gate G1: parasites with 2N DNA content) and
mature schizonts (Gate G2: parasites expressing GFP) are significantly higher (p 
 0.0001) than in ANKAwt infected mice (lower panel).
ANKAwt data obtained from Fonager et al. (6). B, microscopic images of Giemsa-stained blood films showing schizonts of K173cl1 in tail blood
of mice with synchronized infections at 20 h post-infection. In ANKAwt-infected mice, only trophozoites are present in peripheral blood, and
schizonts are absent. Quantitative analysis of circulating schizonts and trophozoites in ANKAwt and K173cl1 infected mice, as determined by
counting Giemsa-stained blood films from tail blood of mice (2.5% to 3% parasitemia) at 20 h after infection, demonstrates the presence of
circulating K173cl1 schizonts (number of irbcs per 5000 RBCs). ANKAwt data obtained from Fonager et al. (6). C, representative distribution
of sequestered schizonts in mice and extracted organs with synchronized infections of parasites that express luciferase under the schizont-
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absence of the characteristic CD36-mediated sequestration
of ANKAwt schizonts in adipose tissue and lungs (Fig. 1C).
The non-sequestering phenotype of K173cl1 parasites may
result from the lack of (expression of) parasite ligands that
adhere to CD36 or from a defective export/transport of such
ligands to the irbc surface. Because it has been shown that
the exported protein SMAC (PBANKA_010060) is involved in
schizont sequestration of ANKAwt (7, 53), we analyzed the
presence and expression of SMAC in K173cl1 parasites. Se-
quencing of the K173cl1 genome showed the presence of a
smac gene that is similar to ANKAwt smac (PBANKA_010060;
two silent mutations are present in the K173cl1 smac gene;
see below). Western analysis using anti-SMAC antibodies and
analysis of a transgenic K173cl1 line that expresses mCherry-
tagged SMAC (smac::mCherryk173cl1; 1276cl1) revealed that
SMAC is expressed and exported to the cytoplasm of
K173cl1 irbcs (Figs. 1D, 1E). These observations indicate that
the non-sequestering phenotype of K173cl1 parasites is not
the result of a lack of expression and export of SMAC.
A Large Proportion of Genetic Differences between Se-
questering ANKAwt and Non-sequestering K173cl1 Are Lo-
cated in Genes Encoding Exported Proteins—We next se-
quenced the K173cl1 genome via whole-genome shotgun
sequencing to a depth of300 coverage and compared the
K173cl1 genome to the existing genome of ANKAwt by map-
ping all sequence reads against the ANKAwt genome, result-
ing in the identification of a total of 5001 protein-encoding
genes of ANKAwt covered by K173cl1 reads. Comparison of
the K173cl1 sequence reads with annotated ANKAwt genes
demonstrated that more than 99% of the genes are shared
between ANKAwt and K173cl1, and for 4121 of the 5001
genes (82%), no differences were detected between the
K173cl1 sequence reads and the annotated ANKAwt genes.
In supplemental Table S5, all “mutated” K173cl1 genes are
shown: (i) genes with insertions/indels (n 	 133), (ii) genes
with deletions (n 	 106), and (iii) genes that contain single
nucleotide polymorphisms (SNPs) (n 	 748). In addition, the
ANKAwt genes (n 	 10) are shown that were absent in the
sequence reads of K173cl1. SNPs were detected in 748
genes, and in 591 of these genes, one or more SNPs were
non-synonymous (supplemental Table S5).
We next searched the literature for all P. berghei proteins
that have been predicted to be exported based on the pres-
ence of the PEXEL motif or on experimental evidence for
export. We generated an “exported protein” list (350 proteins;
supplemental Table S2) that contained all predicted exported
proteins, including the PEXEL-negative members of the BIR
(99 members) and Pb-fam-1 (23 members) protein families.
For members of the BIR family, export has been demon-
strated (4, 22), and in this study we showed that Pb-fam-1
proteins are exported to the irbc cytoplasm. Comparison of
the 748 SNP-containing K173cl1 genes with our list of puta-
tive exported proteins (supplemental Table S1) shows that a
large proportion (54%) of the genes with 5 SNPs encode
exported proteins (n 	 61). In addition, 58% of genes with
deletions of 10% of their sequence (n 	 50) encode ex-
ported proteins, and most genes belong to the subtelomeric
multigene families BIR, Pb-fam-1, and Pb-fam-3 (pyst-c,
TIGR01597; Ref. 6 and supplemental Table S2). These results
demonstrate that a large proportion of genetic differences are
located in genes encoding exported proteins that have a
predominant location in the subtelomeric regions of the chro-
mosomes. Based on the genetic differences observed in
K173cl1 genes encoding exported proteins, we have selected
several genes for further analysis via gene tagging and gene
deletion to identify proteins with putative roles in sequestra-
tion (see supplemental Tables S3 and S4 and the next
sections).
Proteome Analyses of Samples Enriched for Proteins Asso-
ciated with Membranes of Red Blood Cells Infected with P.
berghei ANKA and P. berghei K173—In addition to the ge-
nome analysis of the non-sequestering K173cl1 line, we per-
formed proteome analyses of samples that were enriched for
proteins associated with irbc membranes in order to identify
putative exported proteins. Two different methods were used
to collect membrane fractions of Nycodenz-purified irbcs: the
HL method and the SS method, as described previously (6). In
brief, in the HL-method irbcs were lysed, and membrane
fractions were collected via differential centrifugation. This
method yields samples for trypsin digestion that consist of
irbc surface membranes and other membrane components of
the irbc cytoplasm (e.g. the parasitophorous vacuole) (6, 57).
For the SS method, intact irbcs were incubated with trypsin
for different periods of time, and surface-released proteins
were collected via differential centrifugation. Protein samples
were analyzed by means of capillary LC-MS/MS, and MS/MS
specific ama1 promoter as shown by measuring luciferase activity (RLU, relative light units). ANKAwt-infected mice show the characteristic
CD36-mediated schizont distribution in adipose tissue (belly), lungs, and spleen, whereas K173cl1-infected mice parasites show distribution
throughout the body as shown by luciferase activity in the upper body (lungs, head), decreased sequestration in adipose tissue, and increased
accumulation in the spleen (L, lungs; Li, liver; S, spleen; H, heart; F, belly fat tissue). D, presence of the smac gene in K173cl1 determined via
Southern analysis of separated chromosomes (left-hand panel) and expression of smac in K173cl1 blood stages by means of Northern (middle
panel) and Western analysis with anti-SMAC antibody (lower panel). E, the endogenous smac gene of K173cl1 was C-terminally tagged with
mCherry with DNA construct pL1419 (see “Experimental Procedures”). Correct integration of construct pL1419 in chromosome 1 of line
smac::mCherryK173cl1 was confirmed via Southern analysis of separated chromosomes (left-hand panel). Fluorescence-microscopy analysis of
irbcs of smac::mCherryK173cl1 showed export into the irbc cytoplasm of the tagged protein SMAC::mCherry (red) comparable to the export of
mCherry-tagged SMAC in P. berghei ANKA parasites (line 1262cl2; RMgm-663). Schizonts are shown and nuclei are stained with Hoechst
(blue).
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spectra were searched against a database of tryptic peptides
predicted from all P. berghei ANKA proteins. The HL and SS
proteomes of irbcs infected with sequestering schizonts of
wild-type P. berghei ANKA (ANKAwt) have recently been pub-
lished (6). Here we report additional HL and SS proteomes of
synchronized blood stages of three parasite lines that show
different sequestration phenotypes: (i) trophozoites and schi-
zonts of ANKAwt (schizonts of this line do sequester) (4), (ii)
trophozoites and schizonts of P. berghei K173cl1 (schizonts
of this line do not sequester; see previous sections), and (iii)
schizonts of ANKAsmac. The latter is a genetically modified
mutant of ANKAwt with a strongly reduced schizont seques-
tration (6). We compared the proteome from the sequestering
P. berghei ANKA schizonts with the proteomes of the non-
sequestering P. berghei K173cl1 and ANKAsmac schizonts
and the non-sequestering P. berghei ANKA trophozoites in
order to identify putative proteins that are exported into the
host erythrocyte and which might have either a direct or an
indirect role in the adherence to host cell receptors. Proteins
identified in the 10 different proteomes are shown in supple-
mental Table S1. For further analyses of the proteome data,
we first subtracted all proteins identified as “merozoite spe-
cific” or “merozoite-biased expression” in a P. berghei mero-
zoite proteome analysis as described elsewhere (6) (supple-
mental Table S1). In addition, all proteins identified as
“gametocyte specific” or “gametocyte-biased expression” in
a gametocyte proteome analysis (58) (supplemental Table S1)
were subtracted because the ANKAwt schizont samples were
contaminated with mature gametocytes (39), whereas these
are absent in the non-gametocyte producer K173cl1 parasites
(4). The subtraction of these proteins was used as an initial
filter; however, the HL proteomes in particular also might be
contaminated with other, commonly expressed “housekeep-
ing” proteins. In addition, the subtraction of merozoite- and
gametocyte-specific proteins might result in the removal of
proteins that are located at the irbc membrane.
After subtraction of these proteins, the different proteomes
consisted of 5 to 414 proteins and, as expected, the SS
proteomes of surface-shaved irbcs contained significantly
fewer proteins (5 to 60) than the HL proteomes of enriched
membrane samples (60 to 414 proteins) (Table I, supplemen-
tal Table S1). Fewer proteins were detected in HL proteomes
of ANKAwt schizonts (n 	 177) than in those of trophozoites
(n 	 414), indicating that the number of exported proteins in
the cytoplasm of irbcs decreases when the parasite matures
from the trophozoite to the schizont. In contrast, in SS pro-
teomes of ANKAwt schizonts, more proteins (n 	 36) are
identified than in those of trophozoites (n	 14), indicating that
the irbc surface membranes of schizonts contain a higher
number of parasite proteins than irbc surface membranes of
non-sequestering trophozoites. The total number of proteins
and the number of exported proteins in K173cl1 proteomes
are lower than those numbers in the proteomes of ANKA lines.
These differences might be the result of experimental varia-
tion in sample analysis and/or biological differences between
the two parasite lines. To minimize the experimental variation,
we collected and treated ANKAwt and K173cl1 parasite sam-
ples side by side, and MS analysis was performed side by
side on the same instruments, on the same columns, and over
the same time period. Genome sequencing demonstrated
that both lines contained a very similar total numbers of
genes, but we have evidence that K173cl1 parasites express
lower numbers of BIR and Pb-fam proteins (C.J.J. and B.F.,
unpublished observations). In addition, the K173wt does not
TABLE I












TR ANKA - HL 414 75e 22 6 18
TR K173 - HL 87 14e 5 0 3
SZ ANKA - HL 177 17e 1 5 0
SZ K173 - HL 60 2e 5 0 3
SZ SMAC - HL 194 40e 7 6 11
TR ANKA - SS 12 3 0 0 0
TR K173 - SS 5 3e 0 0 0
SZ ANKA - SS 36 14e 0 3 3
SZ K173 - SS 7 2 0 1 0
SZ SMAC - SS 60 8 0 1 0
All P. berghei genesf 3830 350 99 23 61
a Proteomes of samples enriched for proteins associated with membranes of irbcs. TR, trophozoites; SZ, schizonts; HL, hyptonic lysis of
irbcs; SS, surface shaving of irbcs; ANKA, P. berghei ANKAwt; K173, P. berghei K173cl1; SMAC, P. berghei ANKAsmac. All proteomes were
mapped to P. berghei genes available on the functional annotation from PlasmoDB (release 5.2, 2006).
b Total number of proteins after subtraction of merozoite- and gametocyte-specific genes.
c P. berghei proteins predicted to be exported based on published bioinformatics and experimental analyses (supplemental Table S2).
d P. berghei proteins identified in GeneDB as BIR, Pb-fam-1, and “Plasmodium exported proteins, unknown function.”
e Proteomes that contain significantly more exported proteins relative to the representation of exported proteins in the total genome.
f Numbers of genes (minus pseudogenes, non-protein coding genes) used are as implemented in PlasmoDB release 7.0 (2010).
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produce gametocytes, which might affect the total number of
proteins identified in K173 parasites. Further research is re-
quired in order to define in more detail the differences in
expression of exported proteins between the treated ANKAwt
and K173cl1 parasites and possible differences in exported
proteins between red blood cells containing asexual blood
stages and red blood cells infected with gametocytes.
We next compared the proteomes with our “exported pro-
tein” list, which contained all predicted exported proteins (350
proteins; supplemental Table S2). Most HL and SS proteomes
contained significantly more exported proteins relative to the
representation of exported proteins in the total genome (Table
I). In the SS proteomes, we did not detect any members of
the BIR protein family, and we found only a few members of
the PEXEL-containing proteins defined in GeneDB as “Plas-
modium exported proteins, unknown function” (supplemental
Table S2); in contrast, they are (abundantly) present in all HL
proteomes (Table I). The absence of these proteins in the SS
proteomes suggests that BIR proteins and most “Plasmodium
exported proteins, unknown function” are not exposed on the
surface. In contrast to the absence of these proteins, several
members of the Pb-fam-1 family are identified in the SS
proteomes. The absence of BIRs and the presence of Pb-
fam-1 proteins in the SS proteomes are in agreement with
analyses of the localization of these proteins in protein tag-
ging experiments that show absence and presence at the irbc
surface membrane of BIR and Pb-fam-1, respectively (see the
section “Tagging of 20 Selected Proteins in P. berghei ANKA
Identifies 13 Proteins that Are Exported into the Host
Erythrocyte”).
Using multiple bioinformatics approaches, we have tried to
identify conserved motifs (in addition to the PEXEL motif) in
proteins in the “exported protein” list shown in Table II. Using
a manually assembled training set of 48 exported proteins (17
with and 21 without a signal peptide) and 78 known non-
exported proteins, we performed extensive bioinformatics
analyses to identify additional motifs that are potential dis-
criminating factors. We analyzed these proteins with and with-
out signal peptide (as annotated in PlasmoDB or as predicted
by SignalP 3.0 (59)), which was cleaved in silico from the
exported proteins. The sequence description was done in
Matlab R2009b (MathWorks, Inc., Natick, MA) using bioinfor-
matic toolbox 3.6, and signal peptides were cleaved using a
Matlab script. The performed analyses did not reveal discrim-
inative amino acid features that differed between exported
and non-exported proteins, even if the sequences were di-
vided in subgroups (e.g. aromatic, charged, hydrophobic) or
analyzed with a sliding window instead of the complete se-
quence. Therefore, it is not yet possible to systematically
define the complete repertoire of P. berghei PEXEL-positive
and PEXEL-negative proteins using bioinformatics ap-
proaches, and the discovery of new PEXEL-negative exported
TABLE II
Localization pattern in irbcs of (tagged) exported proteins of P. berghei ANKA as shown in this study and in other published studies
Gene ID Product (name)









PBANKA_083680 Pb-fam-1 (EMAP1) X This study
PBANKA_021550 Plasmodium exported protein, unknown function
(EMAP2)
X This study
PBANKA_132730 Pb-fam-1 X This study
PB403064.00.0 Pb-fam-1 X This study
PBANKA_140030 BIR X This study
PBANKA_000320 BIR X This study
PBANKA_050020 BIR X This study
PBANKA_021600 BIR X This study
PBANKA_031670,
PBANKA_021540
Plasmodium exported protein, unknown function X This study
PBANKA_072260 Plasmodium exported protein, unknown function X This study
PBANKA_010060 Plasmodium exported protein, unknown function
(SMAC)
X (6)
PBANKA_010020 Plasmodium exported protein, unknown function X (20)
PBANKA_136550 Plasmodium exported protein, unknown function
(IBIS1)
X This study, (27)
PBANKA_062310 Conserved rodent malaria protein, unknown
function
X This study
PBANKA_122900 Plasmodium exported protein, unknown function
(PHIST)
X Moreira et al.2
PBANKA_114540 Plasmodium exported protein, unknown function
(PHIST)
X Moreira et al.2
PBANKA_052420 Early transcribed membrane protein (ETRAMP,
SEP2)
X (26)
PBANKA_050110 Early transcribed membrane protein (ETRAMP,
SEP3)
X (26)
a The localization of the (tagged) proteins in parasites and irbcs was determined via (immuno)fluorescence microscopy.
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proteins (PNEPs) will rely on experimental evidence. We
therefore selected a number of proteins for a detailed analysis
of their export and localization in protein-tagging and gene-
deletion experiments (see the next sections). These proteins
were selected based on multiple criteria derived from
genomic, proteomic, and bioinformatics analysis (supplemen-
tal Tables S3 and S4), with the main selection criteria being
their absence in K173cl1 (i.e. absence in the surface
proteomes and/or genome) and in the ANKAsmac surface
proteome. We have primarily performed gene deletion analy-
ses to identify additional proteins that play a role in CD36-
mediated sequestration. All gene deletion mutants were
therefore screened and their sequestration phenotype ana-
lyzed using in vivo imaging and FACS analysis. Supplemental
Tables S3 and S4 show details of the selected proteins and
the main selection criteria for tagging and gene deletion
experiments.
Tagging of 20 Selected Proteins in ANKAwt Identifies 13
Proteins that Are Exported to the Host Erythrocyte—Based on
the above-described proteome and genome analyses, we
selected 20 proteins for C-terminal tagging with the fluores-
cent proteins mCherry or eGFP (supplemental Table S3). Tag-
ging was performed in standard genetic modification experi-
ments in which the endogenous gene was stably tagged with
either mCherry or gfp by means of a single-crossover integra-
tion of the tagging construct (supplemental Fig. S2A). Proteins
selected for tagging included members of the PEXEL-nega-
tive BIR protein family (four proteins) and Pb-fam-1 protein
family (three members) and two PEXEL-positive proteins,
identified as Pb-fam-3 proteins in GeneDB (version January
2010). Fluorescence-microscopy analysis of live irbcs of 20
transgenic parasite lines that expressed tagged proteins re-
vealed that for two proteins, no fluorescence signal could be
detected in blood stages. Of the remaining 18 tagged pro-
teins, 13 were exported to the cytoplasm of the erythrocyte
and 5 were predominantly located in the cytoplasm of the
parasite (supplemental Fig. S3). We observed three different
localization patterns of the exported proteins (Figs. 2–5, Table
II, supplemental Tables S3, S4): (i) a diffuse and/or patchy
location in the cytoplasm (nine proteins), (ii) a punctate, ves-
icle-like localization in the cytoplasm (two proteins), and (iii) a
location at the irbc membrane (two proteins). Eight of the nine
tagged members of the BIR, Pb-fam-1, and Pb-fam-3 families
were expressed and were exported (Figs. 2, 3). Except for one
Pb-fam-1 member (PBANKA_083680; see the subsequent
section), none of these proteins showed distinct localization at
the surface membranes of infected cells. The mCherry signal
of the tagged proteins was dispersed throughout the irbc
cytoplasm and did not show overlap with the erythrocyte
membrane signal of TER119 antibodies (Fig. 2). The lack of a
surface location of the PEXEL-negative BIR and PEXEL-pos-
itive Pb-fam-3 proteins is in agreement with the absence of
these proteins in the surface-shaved proteomes of irbcs (Ta-
ble I). Those proteins with a diffuse staining pattern in the
cytoplasm of trophozoites and young schizonts often show a
more patchy localization in mature schizonts (Figs. 2, 3). In
addition to the proteins belonging to the multigene families,
we identified four proteins encoded by single-copy genes that
were exported into the cytoplasm of the irbcs (Figs. 3, 5). One
of these proteins (PBANKA_070110) does not contain a dis-
tinct PEXEL motif and shows diffuse staining similar to that
observed in the members of the multigene families. Two pro-
teins (PBANKA_062310 and PBANKA_136550) showed a dis-
tinct localization pattern with a punctate, vesicle-like staining
pattern in the irbc cytoplasm. PBANKA_062310 has a pre-
dicted signal peptide and lacks a PEXEL and a transmem-
brane domain, whereas PBANKA_136550 contains a PEXEL
motif and transmembrane domain but lacks a predicted signal
peptide (Fig. 4). One PEXEL-positive protein (PBANKA_
021550) shows an irbc membrane location (see the subsequent
section).
The Exported Proteins EMAP1 and EMAP2 Are Transported
to the irbc Membrane in ANKAwt but Do Not Play a Role in
Sequestration of the Schizont Stage—Two out of the 13 ex-
ported proteins showed clear localization at the irbc mem-
brane as shown by (immuno-) fluorescence analysis of live
irbcs that were stained with the erythrocyte surface-mem-
brane-specific TER119 antibody (Figs. 4, 5). One protein,
PBANKA_083680, is a PEXEL-negative protein encoded by a
member of the pb-fam-1 multigene family, referred to here as
erythrocyte membrane associated protein 1 (EMAP1), and the
other, PBANKA_021550, is a PEXEL-positive protein encoded
by a single copy gene, referred to here as EMAP2. Analysis
of P. berghei ANKA expressing EMAP1::mCherry (emap1::
mCherryANKA) via FACS and fluorescence microscopy showed
that between 80% and 100% of the irbcs expressed EMAP1
(Figs. 4A, 4B). The percentage of EMAP1::mCherry expressing
blood stages remained stable during multiple mechanical pas-
sages into naive mice and during mosquito transmission (B.F.
and J.B., unpublished observations). In blood stages of syn-
chronized infections, EMAP1::mCherry and EMAP1::eGFP were
expressed in trophozoites and in schizonts but not in ring forms.
In young trophozoites, 8 to 12 hours post-invasion (hpi),
mCherry/GFP signals were mainly detected in the parasite cy-
toplasm. Between 12 and 16 hpi, the protein was detected
at the irbc membrane (Fig. 4C). In contrast to EMAP1, two
other mCherry-tagged members of the Pb-fam-1 family
(PBANKA_132730; PB403064.00.0), although exported into the
red blood cell cytoplasm, did not show distinct surface local-
ization (Fig. 2). Both members were expressed in a high per-
centage of irbcs (75% to 100%; B.F. and J.B., unpublished
observations), and in all irbcs a diffuse staining pattern of the
cytoplasmwas observed. Analysis of P. berghei ANKA express-
ing EMAP2::mCherry (emap2::mCherryANKA) showed an irbc
membrane location of EMAP2 similar to that of EMAP1 (Fig. 5).
EMAP2::mCherry is expressed by 80% to 100% of the para-
sites, as shown by FACS and fluorescence microscopy (Figs.
5A–5C). Relative to EMAP1, expression of EMAP2 starts early
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during blood stage development, and the protein is already
abundantly present at the irbc membrane of the (non-seques-
tering) young trophozoites at 8 to 12 hpi (Fig. 5C). After live irbcs
of emap1::mCherryANKA and emap2::mCherryANKA were
stained with anti-mCherry antibodies, only a low percentage of
schizont-containing irbcs were stained (7%  2% and 6% 
3%, respectively) as determined via FACS analysis (Figs. 4B,
5B) and confirmed via fluorescence microscopy (Figs. 4D, 5D).
We further analyzed whether EMAP1 and EMAP2 played a
role in sequestration of the schizont stage. We first analyzed
the EMAP location in two lines of P. berghei that show no
(K173cl1) or strongly reduced (ANKAsmac) sequestration of
schizonts. The proteins in these parasite lines were tagged
with mCherry as described for the tagging of EMAP proteins
in ANKAwt. Analysis via fluorescence microscopy of live irbcs
showed that in ANKAsmac, both proteins were located at
FIG. 2. Localization of different members of three protein-families in live P. berghei ANKA infected red blood cells (irbcs) as
determined via fluorescence microscopy of fluorescently tagged proteins. Blood stages are shown for two Pb-Fam-3 family members (A),
three BIR family members (B), and two Pb-Fam-1 family members (C). In supplemental Table S3, the gene IDs (GeneDB) of these proteins are
given. All proteins show a diffuse or patchy localization in the irbc cytoplasm. mCherry (red) or eGFP (green) fluorescence is detected mainly
in the cytoplasm and not at the surface of the irbc membrane, which is stained with TER119 antibody (green). Parasite nuclei are stained with
Hoechst (blue).
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the irbc membrane in a manner comparable to their location in
ANKAwt (Figs. 4E, 5E). The presence of both proteins at the
irbc membrane demonstrates that SMAC is not essential for
the transport or the irbc membrane location of these proteins.
In irbcs of K173cl1, the EMAP2 protein also was located at the
irbc membrane (Fig. 5E). However, in this line, EMAP1 is not
transported to the irbc membrane, and the protein showed
(diffuse) location in the irbc cytoplasm (Fig. 4E). In addition to
the localization of the EMAPs in non-sequestering parasites,
we analyzed the sequestration phenotype in gene deletion
mutants in ANKAwt parasites that lack the expression of
EMAPs. In supplemental Fig. S1B, a schematic of the gene
deletion construct and the disruption event is shown. The
gene deletion mutants, emap1 and emap2, were generated
in the reporter line ANKA-GFP-Lucschiz, enabling the quanti-
fication of schizonts in peripheral blood (tail blood) via FACS
analysis and the quantification of schizont tissue distribution
by means of real-time in vivo imaging. Both gene deletion
mutants showed a normal sequestration phenotype that was
not different from that of the wild type (Fig. 6). Analysis of tail
blood through FACS and Giemsa-stained smears showed no
evidence of schizonts in the circulation (Fig. 6B), and imaging
showed a normal tissue distribution of schizonts (i.e. seques-
tration in adipose tissue and lungs) (Fig. 6C). Combined, these
results demonstrate that neither EMAP1 nor EMAP2 plays any
direct role in the sequestration of schizonts.
Targeted Disruption of Genes Encoding Putative Exported
Proteins Shows a High Level of Redundancy in the Function of
Exported Proteins—We selected a number of putative ex-
ported proteins from the proteome and genome analyses for
gene deletion experiments. We performed these gene dele-
tion analyses to identify additional proteins that play a role in
CD36-mediated sequestration. All gene deletion mutants
were therefore screened for their sequestration phenotypes
by means of in vivo imaging and FACS analysis. Gene deletion
was performed via standard genetic modification technolo-
gies for the deletion of P. berghei genes by double-crossover
integration (supplemental Fig. S2B). All gene deletion mutants
were generated in wt-GFP-Lucschiz, which allowed the quan-
tification of schizonts in tail blood via FACS analysis (7, 53).
The results of the targeted disruption of 30 genes that had
been selected on basis of their presence in membrane-en-
riched proteomes of ANKAwt schizonts have recently been
published. We here report the analysis of an additional 20
genes that were selected based on the proteome and genome
analyses presented in this study (supplemental Table S4). The
20 genes reported here include a member of the ETRAMP
family of proteins (PBANKA_051700), orthologs of P. falcipa-
rum clag2/3 (PBANKA_140060) and clag9 (PBANKA_083630)
genes, and five “Plasmodium exported proteins, unknown
function” (PBANKA_122900, PBANKA_070060, PBANKA_
120060, PBANKA_136550, PBANKA_021550). In total, 21 out
of 50 genes were refractory to gene deletion in multiple ex-
periments, suggesting that these genes have an essential role
during blood stage growth. For 29 genes we were able to
select gene-deletion mutants. Apart from smac (6), none of
the 29 gene-deletion mutants showed a significant increase of
schizonts in the peripheral circulation (6) (supplemental Table
S4). Only 3 mutants out of 20 mutants that were analyzed for
their rate for asexual multiplication (supplemental Table S4
and Ref. 6) showed a consistently lower multiplication rate
FIG. 3. Localization of different P. berghei proteins (encoded by
single-copy genes) in live infected red blood cells (irbcs) as de-
termined via fluorescence microscopy of mCherry- or eGFP-
tagged proteins. A, localization of three different proteins in ANKAwt
parasites showing either a diffuse/patchy localization or a punctate,
vesicle-like localization in the irbc cytoplasm. mCherry (red) or eGFP
(green) fluorescence is detected mainly in the cytoplasm and not at
the surface of the irbc membrane, which is stained with TER119
antibody (green). Parasite nuclei are stained with Hoechst (blue). B,
localization of mCherry-tagged PBANKA_136550 in ANKAsmac and
K173cl1 parasites showing the same punctate, vesicle-like localiza-
tion in the irbc cytoplasm as in ANKAwt parasites (see A). BF, bright
field.
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FIG. 4. EMAP1 (PBANKA_083680) is associated with the irbc membrane of P. berghei ANKA irbcs. A, schematic of mCherry-tagged
EMAP1 showing the location of the predicted signal peptide (sp) and the P. yoelii subtelomeric A domain (PYST- A). B, analysis of
emap1::mCherry parasites. Left panel: Southern analysis of separated chromosomes shows integration of the tagging construct into
chromosome 8. Middle panel: Western analysis of EMAP1::mCherry expression using anti-mCherry antibodies. As a loading control (ctrl) for
wild-type (wt) parasites, we used the aspecific reaction of the antibodies with a 20 kDa parasite protein. Right panel: FACS analysis of
mCherry-expressing schizonts. In the first dot plot, the irbcs are selected based on Hoechst and mCherry fluorescence. An average percentage
of 87% ( 4; n 	 5; Gate 2) of the total number of schizonts (Gate 1) is mCherry positive. In the second dot plot, the irbcs were selected
based on Hoechst and FITC fluorescence after staining with primary anti-mCherry antibodies and secondary FITC antibodies. An average
percentage of 7% ( 2; n 	 2; Gate 2) of the total number of schizonts (Gate 1) is FITC positive. Gate 1 (G1): mature schizonts (8–16N); Gate
2: mCherry- or FITC-positive schizonts. C, irbc membrane location of EMAP1 in live blood stages of ANKAwt as shown by fluorescence
microscopy of mCherry- (red) or eGFP (green)-tagged EMAP1. Nuclei are stained with Hoechst (blue). D, detection of EMAP1::mCherry at
the surface of live irbcs via staining with primary anti-mCherry antibodies and secondary FITC antibodies (green). BF, bright field. E, irbc
membrane location of EMAP1 in live blood stages of ANKAwt and ANKAsmac as shown by fluorescence microscopy of mCherry-tagged
EMAP1 (red). In K173cl1 blood stages, EMAP1::mCherry shows a more diffuse and patchy localization in the cytoplasm of irbcs, with no distinct
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(i.e. the mutants lacking expression of PBANKA_021550,
PBANKA_136550, and SMAC). In mice infected with the mu-
tant lacking PBANKA_136550, we occasionally observed
small numbers of schizonts in Giemsa-stained smears of tail
blood. We therefore analyzed this mutant in more detail (sup-
plemental Fig. S6) for its sequestration phenotype by means
of in vivo imaging and FACS analysis. In addition, we analyzed
the timing of the expression of PBANKA_136550 in wild-type
parasites and in the non-sequestering K173cl1 and
ANKAsmac parasites. These analyses showed a normal se-
questering phenotype of mutant schizonts (supplemental
Fig. S5D) and normal expression and localization of the
PBANKA_136550 protein in blood stages of non-sequestering
K173cl1 and ANKAsmac parasites (Fig.3B).
The successful disruption of 29 out of 50 genes encoding
blood-stage expressed proteins without a distinct effect on
the growth phenotype indicate that there is a high level of
functional redundancy of these proteins. Table III shows de-
tails of 34 genes that encode putative exported P. berghei
proteins that have been targeted for gene deletion in this
study and in other studies. Fourteen of these genes have been
successfully disrupted, and this has resulted in the selection
of one mutant with a reduced CD36-mediated sequestration
phenotype (mutant smac) and four mutants with a reduced
asexual multiplication rate (supplemental Table S4).
DISCUSSION
In this study, using proteomic, genomic, and reverse-ge-
netic approaches, we created lists of potential irbc resident P.
berghei proteins and were able to demonstrate that 13 of
these proteins are exported into the cytoplasm of the host
erythrocyte. These proteins include both PEXEL-positive ex-
ported proteins and PNEPs, and our studies reveal for the first
time the export of members of the PEXEL-negative family,
Pb-fam-1, a protein family that consists of 23 members. Along
with the 100 or so PEXEL-negative BIR proteins, the P. ber-
ghei genome encodes more than 120 PNEPs. In addition to
the BIR and Pb-fam-1 proteins, we found the export of PNEPs
that are encoded by genes that do not belong to large multi-
gene families. These observations demonstrate that P. ber-
ghei has a large repertoire of exported proteins that lack a
distinct PEXEL motif. For Plasmodium species that encode
relatively few PEXEL-positive proteins, it has been proposed
that PNEPs might play a more prominent role in host cell
remodeling (21). The export of PNEPs suggests that motifs
that are different from the PEXEL motif are recognized by the
Plasmodium export machinery (37) or that alternative PEXEL-
independent export pathways exist (20, 21). Using multiple
bioinformatics approaches, we have tried to identify con-
served motifs in exported proteins in addition to the PEXEL
motif, but we have been unable to determine any clear feature
that could discriminate PNEPs from non-exported proteins.
Based solely on bioinformatics comparisons, it is not yet
possible to define the complete repertoire of P. berghei
PNEPs. At present, therefore, the discovery of new PNEPs
relies on experimental approaches as presented in this study.
In this context, it should be noted that the P. falciparum
PNEPs also do not appear to possess a discernable sequence
structure or motif in common (21).
In previous studies, the identification of P. berghei exported
proteins was based mainly on comparison with orthologs of
the PEXEL-positive proteins of P. falciparum, which resulted
in the identification of only 11 to 33 putative exported proteins
(14, 15, 19). Recently, we performed an HMM analysis of the
PEXEL motif in P. berghei proteins using an updated annota-
tion of the P. berghei genome, which resulted in the identifi-
cation of many more PEXEL-positive proteins (438 proteins)
with at least 75 proteins when a stringent HMM-score cutoff
value of 2 was used (6). This analysis demonstrates that the
P. berghei genome contains a much higher number of puta-
tive exported proteins than is predicted based on compari-
sons with P. falciparum exported proteins. If one combines
the 75 PEXEL-positive proteins with the P. berghei PNEPs
and P. berghei orthologs of P. falciparum PNEPs, the total
number of P. berghei (putative) exported proteins is greater
than 350 (supplemental Table S3, Table III).
Our analyses of the cellular location of fluorescently tagged
proteins show that exported proteins can have distinct loca-
tions within the host erythrocyte. Unexpectedly, most proteins
belonging to the PEXEL-negative BIR and Pb-fam1 families
and members of the PEXEL-positive Pb-fam-3 families did not
show a distinct irbc membrane location and instead were
found to be distributed throughout the red blood cell cyto-
plasm. These observations lead to questions about whether
these proteins play any role in CD36-mediated schizont se-
questration, and it is unlikely that they interact with host cell
receptors in a way analogous to P. falciparum PfEMP1. It is
possible that in our studies either the fluorescent tag pre-
vented the correct location at the surface of the irbc mem-
brane or only a relatively small amount of these proteins
reached the surface membrane of schizonts, and conse-
quently the signal was undetectable by standard fluorescence
microscopy. However, the complete absence of all BIR and
Pb-fam-3 members in our surface-shaved irbc proteomes
supports the conclusion that these proteins are not exposed
on the outside of the irbc membrane. Also, the observation
that these proteins exhibit similar expression and location
patterns in (non-sequestering) gametocyte-infected erythro-
irbc membrane localization. The irbc surface membrane is stained with TER119 antibody (green), and nuclei are stained with Hoechst (blue).
F, localization of EMAP1 in fixed irbcs as determined via immunofluorescence microscopy after staining with primary anti-EMAP1 antibodies
and secondary Alexa 594 antibodies. These analyses confirm the association of EMAP1 with the irbc membrane in ANKAwt and ANKAsmac
parasites and the more diffuse or patchy localization in K173cl1.
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FIG. 5. EMAP2 (PBANKA_021550) is associated with the irbcmembrane of P. berghei ANKA irbcs. A, schematic of mCherry-tagged EMAP2
showing the location of the predicted signal peptide (SP), PEXEL motif, and regions containing repeats (RPT) detected by Prospero but not covered
by domains (SMART sequence analysis). B, analysis of emap2::mCherry parasites. Left panel: Southern analysis of separated chromosomes shows
integration of the tagging construct into chromosome 2. Middle panel: Western analysis of EMAP2::mCherry expression using anti-mCherry
antibodies. As a loading control (ctrl) for wild-type (wt) parasites, we used the aspecific reaction of the antibodies with a 20 kDa parasite protein.
Right panel: FACS analysis of mCherry-expressing schizonts. In the first dot plot, the irbcs were selected based on Hoechst and mCherry
fluorescence. An average percentage of 89% ( 3; n 	 3; Gate 2) of the total number of schizonts (Gate 1) is mCherry positive. In the second dot
plot, the irbcs were selected based on Hoechst and on FITC fluorescence after staining with primary anti-mCherry antibodies and secondary FITC
antibodies. An average percentage of 6% ( 3; n 	 2; Gate 2) of the total number of schizonts (Gate 1) is FITC positive. Gate 1 (G1): mature
schizonts (8–16N); Gate 2: mCherry- or FITC-positive schizonts. C, irbc membrane location of EMAP2 in live blood stages of ANKAwt as shown
by fluorescence microscopy of mCherry-tagged EMAP2 (red). The irbc surface membrane is stained with TER119 antibody (green), and parasite
nuclei are stained with Hoechst (blue). D, detection of EMAP1::mCherry at the surface of live irbcs via staining with primary anti-mCherry antibodies
and secondary FITC antibodies (green). E, irbc membrane location of EMAP2 in live blood stages of ANKAsmac and K173cl1 as shown by
fluorescence microscopy of mCherry-tagged EMAP2 (red). The irbc surface membrane is stained with TER119 antibody (green), and parasite nuclei
are stained with Hoechst (blue).
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FIG. 6. Parasites lacking expression of EMAP1 and EMAP2 show a normal schizont sequestration phenotype. A, genotype analysis of
emap1 and emap2 confirming correct deletion of these genes. Southern analysis of separated chromosomes shows integration of the
tagging construct in chromosome 8 and chromosome 2 for emap1 and emap2, respectively, using probes recognizing the 3utr dhfr and
the hdhfr regions of the constructs. Western analysis using anti-EMAP1 antibodies shows the absence of EMAP1 in emap1. As a loading
control (ctrl) for wild-type (wt) parasites, we used Hsp70 antibodies. A, Northern analysis shows absence of emap2 transcripts in emap2 using
an emap2 probe; as a ctrl for wt parasites, we used an a/b-large subunit rRNA oligo probe. B, FACS analysis of the presence of schizonts in
the peripheral blood circulation in mice (n 	 4) with asynchronous infections of emap1, emap2, the sequestering ANKA-GFP-Lucschiz, and
the non-sequestering K173cl1-GFP-Lucschiz. Tail blood of infected mice with parasites expressing GFP-luciferase (under the ama-1 promoter)
was stained with Hoechst and analyzed for Hoechst and GFP fluorescence. Only in K173cl1-GFP-Lucschiz-infected mice was the number of
schizonts (Gate G1: parasites with 2N DNA content) and mature schizonts (Gate G2: parasites expressing GFP) significantly higher (p 
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cytes (B.F. and C.J.J., unpublished observations) indicates
that these proteins do not function as ligands that mediate
irbc adherence to endothelial cell receptors. However, we
have analyzed the location of only a limited number of mem-
bers of the different families, and it is possible that within
these families a subgroup of proteins is transported to the irbc
surface membrane. For P. vivax VIRs and P. chabaudi CIRs,
there is evidence that structurally different subgroups exist
that might have different cellular destinations (25, 62), and for
P. yoelii, evidence has been presented in support of a surface
location of YIRs in a low proportion of irbcs (6, 63). However,
a clear role in irbc sequestration of these proteins has not
been proven, although P. vivax VIRs appear to bind to ICAM1
in vitro (25, 64).
In contrast to the diffuse cytoplasmic location of BIRs and
Pb-fam-3 members and their apparent absence at the surface
of P. berghei irbcs, both proteome and tagging experiments
support an irbc surface membrane location of Pb-fam-1 fam-
ily members. In our proteomes of surface-shaved irbcs, sev-
eral Pb-fam-1 proteins were detected, and one of the three
Pb-fam-1 proteins we tagged showed a distinct irbc mem-
brane location. The absence of an irbc membrane location of
two other Pb-fam-1 members supports observations that dif-
ferent members of a protein family can have different cellular
locations (25). In addition to the PEXEL-negative Pb-fam-1
protein (EMAP1), we also observed a distinct irbc membrane
location of the PEXEL-positive protein PBANKA_021550
(EMAP2), which is not encoded by a multigene family. These
two proteins are the first P. berghei proteins for which an irbc
membrane location has been observed, a finding that dem-
onstrates that both PNEPs and PEXEL-containing proteins
can reach the irbc membrane. Despite these proteins’ irbc
membrane location, various lines of evidence suggest that
they have no direct role in the adherence of irbcs to host
endothelial cells. First, we did not find strong evidence of
extracellular exposure of these proteins on the outside of the
irbc membrane by staining live irbcs using anti-mCherry an-
tibodies. Only a low percentage of schizont-containing irbcs
were stained with these antibodies, indicating that either a low
percentage of irbcs expose these proteins on the outside of
the irbc or these proteins are not on the outside of the irbc and
staining results from entry of the mCherry antibodies into irbcs
that have a damaged or leaky surface membrane. It is of
course possible that only the N-terminal portion of the EMAPs
is exposed on the outside of the irbcs and that the fluorescent
tags at the C-terminus of these proteins were not accessible
to antibody detection. EMAP2 is an abundantly expressed
protein that is already present at the irbc membrane of young,
non-sequestering trophozoites, and this protein is also pres-
ent at the irbc membrane of non-sequestering schizonts of
the K173cl1 line. These observations also indicate that
EMAP2 is not a ligand that directly interacts with host cell
receptors. The absence of EMAP1 at the irbc membrane
might indicate that the K173cl1 has a “general defect” in
trafficking proteins to the irbc membrane, which might explain
the “lack of sequestration” phenotype. In contrast, EMAP2 is
located at the irbc membrane, demonstrating that proteins of
this line can reach the membrane. Moreover, EMAP1 is a
member of a multigene family, and therefore it is possible that
its absence at the irbc membrane is not due to a trafficking
defect but results from different locations of members of a
single protein family in different strains. We have examined
and compared the genomes of K173cl1 and ANKAwt for
mutated (or absent) genes in K173cl1, which could explain
defects in export machinery, but so far we have been unable
to identify suitable candidates. Most proteins that could be
involved in export (for example, SMAC) were expressed by
K173cl1. Further research, including functional analysis via
reverse genetics, is required to investigate putative defects in
the trafficking machinery of K173cl11.
Finally, targeted disruption of both emap1 and emap2
genes in sequestering ANKAwt parasites had no effect on the
sequestration phenotype of schizonts. Whereas the gene-
deletion experiments demonstrate a non-essential role for
EMAP2 in irbc sequestration, the role of EMAP1 in seques-
tration is complicated by the fact that this protein is encoded
by a multigene family. We have found evidence of the simul-
taneous expression of multiple Pb-fam-1 proteins in a single
P. berghei infected erythrocyte (B.F. and C.J.J., unpublished
observations), and it is therefore possible that other Pb-fam-1
members may take over the location and the function of
EMAP1 in gene-deletion mutants. Additional research is re-
quired to unravel the role, if any, that Pb-fam-1 proteins play
in sequestration.
For two proteins we observed a location that is clearly
different from both the diffuse cytoplasmic location of BIRs
and Pb-fam-3 and the irbc membrane location of EMAP1
and EMAP2. These proteins, PBANKA_062310 and
PBANKA_136550, have a distinct, punctate, vesicle-like
staining pattern in the irbc cytoplasm. These observations
might indicate that P. berghei creates intracellular membra-
nous networks in the host erythrocyte, like P. falciparum,
where Maurer’s clefts (36, 65, 66), J-dots (67, 68), and addi-
tional vesicles (66) form membranous networks that contrib-
0.0001) than in ANKA-GFP-Lucschiz-infected mice (lower panel). C, representative tissue distribution of sequestered schizonts in mice infected
with emap1, emap2, the sequestering ANKA-GFP-Lucschiz, and the non-sequestering K173cl1-GFP-Lucschiz. Both emap1- and emap2-
infected mice show the characteristic CD36-mediated schizont-distribution in adipose tissue (belly), lungs, and spleen, comparable to the
sequestering ANKA-GFP-Lucschiz. In contrast, the non-sequestering K173cl1-GFP-Lucschiz-infected mice parasites show distribution through-
out the body, as shown by luciferase activity in the upper body (lungs, head), decreased sequestration in adipose tissue, and increased
accumulation in the spleen.
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ute to the transport of proteins and remodeling of the host
cell. A recent study (27) similarly showed a punctate vesicle as
we have observed for PBANKA_136550. In this article, evi-
dence is presented to support its association with discrete
membranous structures in the erythrocyte cytoplasm termed
“intraerythrocytic P. berghei-induced structures.” Through the
TABLE III
Putative exported proteins of P. berghei ANKA that have been targeted for gene deletion in this study and in other published studies




PBANKA_010060 Conserved rodent malaria protein,
unknown function
SMAC Yes Reduced sequestration,
reduced growth
(6)
PBANKA_021550 Plasmodium exported protein,
unknown function
EMAP2 Yes Reduced growth This study
PBANKA_020890 Conserved Plasmodium protein,
unknown function
No – (14)
PBANKA_021480 Heat shock protein, putative No – This study
PBANKA_021550 Plasmodium exported protein,
unknown function
Yes No phenotype This study
PBANKA_030500 Serine repeat antigen 2 Yes No phenotype (75)
PBANKA_030510 Serine repeat antigen 1 Yes No phenotype (75)
PBANKA_041090 Conserved Plasmodium protein,
unknown function
No – (14)
PBANKA_050110 Early transcribed membrane
protein
ETRAMP; SEP3 No – (26)
PBANKA_050260 Conserved Plasmodium protein,
unknown function
No – (14)
PBANKA_052060 Enhancer of rudimentary
homolog, putative
No – This study
PBANKA_052420 Early transcribed membrane
protein
ETRAMP; SEP2 No – (26)
PBANKA_052480 Early transcribed membrane
protein
ETRAMP; SEP1 Yes No phenotype (26)
PBANKA_061060 Conserved Plasmodium protein,
unknown function
No – (14)
PBANKA_062310 Conserved rodent malaria protein,
unknown function
No – (6)
PBANKA_070060 Plasmodium exported protein,
unknown function
Yes No phenotype This study
PBANKA_070070 Plasmodium exported protein,
unknown function
Yes No phenotype (6)
PBANKA_070110 Conserved Plasmodium protein,
unknown function
Yes No phenotype (6)
PBANKA_083630 Cytoadherence linked asexual
protein 9
CLAG9 No –
PBANKA_083680 Pb-fam-1 EMAP1 Yes No phenotype This study
PBANKA_100760 Conserved Plasmodium protein,
unknown function
No – (14)
PBANKA_110140 Rhoptry-associated protein 2/3 No – (76)
PBANKA_100850 Translocon component PTEX150 PTEX150 No – (37)
PBANKA_113620 Conserved Plasmodium protein,
unknown function
No – (14)
PBANKA_114540 Plasmodium exported protein,
unknown function
PHIST No – (79)
PBANKA_120060 Plasmodium exported protein,
unknown function
Yes No phenotype This study
PBANKA_122900 Plasmodium exported protein,
unknown function
PHIST Yes No phenotype This study
PBANKA_132710 Conserved Plasmodium protein,
unknown function
No – (14)
PBANKA_134910 Merozoite surface protein 7 MSP7 Yes Reduced growth (5)
PBANKA_135330 ABC transporter, putative No – (14)
PBANKA_136550 Plasmodium exported protein,
unknown function
IBIS1 Yes Reduced growth (27), this study
PBANKA_141470 ADP-ribosylation factor, putative No – (14)




PBANKA_144900 Conserved Plasmodium protein,
unknown function
No – (14)
a Successful and unsuccessful attempts to generate gene deletion mutants via standard genetic modification technology.
b The sequestration phenotype was analyzed for the determination of schizonts in tail blood by means of FACS and Giemsa-stained blood
film analysis and in vivo imaging of schizont tissue distribution. The growth phenotype was analyzed by measuring the multiplication rate of
asexual blood stages in mice.
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heterologous expression of P. falciparum Maurer’s cleft pro-
teins in P. berghei, Ingmundson et al. (27) showed the co-
localization of these proteins with PBANKA_136550 (IBIS1),
suggesting that these structures might have a function similar
to that of Maurer’s clefts. Two recent studies also show the
formation of vesicle-like structures in P. berghei infected
erythrocytes. Curra et al. (26) show that two PEXEL-negative
ETRAMP proteins are transported in vesicles from the para-
sitophorous vacuole membrane into the erythrocyte cyto-
plasm. Evidence was found of the anchoring of these
ETRAMP-containing vesicles to the erythrocyte membrane
skeleton (26), and we found both these ETRAMPs in our
proteomes of membrane-enriched samples. In addition,
Moreira et al.2 found a vesicle-like location and an association
with membranous structures for two PEXEL-positive proteins,
PBANKA_114540 and PBANKA_122900; again, these pro-
teins are present in our proteomes. These proteins contain a
predicted 160 aa domain, termed PHIST, that characterizes a
large family of over 60 proteins in P. falciparum and 3 mem-
bers in P. berghei. Moreira et al.2 show that two members of
the P. falciparum PHIST family are associated with Maurer’s
clefts. In conclusion, the findings on the association of various
PNEPs and PEXEL-positive proteins with vesicle-like mem-
branous structures suggest that P. berghei use transport ma-
chinery that is comparable to that of P. falciparum. The asso-
ciation of Maurer’s cleft proteins to these structures might
also suggest that host remodeling and protein trafficking are
far more conserved among Plasmodium species than previ-
ously proposed (27). These observations are supported by
studies showing that red-blood-cell-targeting motifs of P. fal-
ciparum proteins can function in P. berghei (20, 69) and,
moreover, P. berghei also expresses homologues of the P.
falciparum translocon (PTEX) known to be essential for the
export of protein into the irbc cytoplasm (37).
Our gene-deletion studies revealed high levels of functional
redundancy among the proteins that were found in our mem-
brane-enriched proteomes of irbcs. Nearly 60% of the 50
genes that we selected for gene-deletion were successfully
deleted from the genome (this study and Ref. 6), indicating
that these proteins have a dispensable role during asexual
blood stage multiplication. In part, this might not be unex-
pected, as a number of these proteins are encoded by mul-
tigene families, and presumably other family members might
take over the function of the absent protein. However, the
indispensability of a protein can differ between members of
the same family. For example, the ETRAMP member
PBANKA_051700 can be deleted in ANKAwt, and the protein
is absent in the proteomes of K173cl1 (supplemental Table
S1), indicating that this gene is not essential in blood stages.
In contrast, for two other ETRAMP members, gene-deletion
mutants could not be selected (26), suggesting a critical role
of these proteins in blood stages. A similar observation was
made in two predicted PHIST domain proteins of P. berghei.
The PBANKA_122900 gene could be disrupted (this study and
Moreira et al.2), indicating a non-essential role, which is sup-
ported by the partial deletion of the same gene in K173cl1
(supplemental Table S5). In contrast, attempts to disrupt the
other PHIST encoding gene, PBANKA_114540, were unsuc-
cessful,2 and the presence of the complete gene in the
K173cl1 genome is supportive of a vital role of this protein in
blood stages. Our genes selected for deletion included sev-
eral orthologs of P. falciparum genes for which a role in
sequestration has been proposed, such as clag9 (70) and
clag2/3 (71); these two genes were refractory to gene dele-
tion. Our gene-deletion studies have so far identified one P.
berghei protein, SMAC, that plays a role in CD36-mediated
schizont sequestration. It is unlikely that SMAC directly inter-
acts with CD36 because SMAC is not located at the surface of
the irbc membrane (6). It has been proposed that SMAC is
involved in either transport or anchoring of parasite ligands at
the red blood cell surface membrane. Indeed, the transport of
multiple proteins to the irbc membrane, as shown in this
study, suggests that P. berghei actively modifies the erythro-
cyte membrane. Interestingly, both EMAP1 and EMAP2 lack
transmembrane domains, which suggests that their associa-
tion with the irbc membrane is accomplished through com-
plex formation with other parasite proteins. Both EMAP1 and
EMAP2 were located at the irbc membrane in mutants lacking
SMAC, and therefore they are likely to be transported and
anchored at the irbc membrane by a SMAC-independent
pathway.
It has been thought that P. falciparum evolved a largely
unique and complex mechanism of parasite protein export
into the irbc. Our observations support the conclusion that
trafficking of P. berghei proteins into discrete compartments
and locations inside and at the surface of the irbc is highly
analogous to the trafficking mechanisms employed by P.
falciparum in human red blood cells. Thus protein trafficking in
Plasmodium is likely to be similarly complex across different
species, not only in terms of the cellular localization of pro-
teins, which likely results from similar molecular processes,
but also in the large and diverse repertoire of PEXEL-positive
and PEXEL-negative proteins that are found inside irbcs, the
majority of which are encoded by Plasmodium-specific multi-
gene families. The identification of proteins exported to the
surface of P. berghei irbcs should aid in the development of
small-animal models that could be exploited to analyze the
sequestration properties of P. falciparum ligands in vivo (6,
72). For example, this information could be used to generate
transgenic P. berghei parasites expressing modified chimeric
P. berghei proteins fused to receptor binding domains of P.
falciparum PfEMP-1 on the surface of rodent irbcs. This, in
conjunction with mice expressing human receptors (e.g. hu-
2 Cristina K. Moreira, Alida Coppi, Brandy L. Bennet, Elena Aime,
Blandine Franke-Fayard, Chris J. Janse, Isabelle Coppens, Photini
Sinnis, Thomas J. Templeton no change in publication status, sub-
mitted for publication.
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man ICAM-1 (73) and the use of in vivo imaging, might create
in vivo screening assays to test inhibitors that block P. falcip-
arum sequestration and thereby enhance the development of
adjunctive therapeutic strategies to reduce severe and cere-
bral malaria-associated mortality (74).
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